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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYReports on the retention of somatic cell memory in induced pluripotent stem cells (iPSCs) have complicated the selection of the optimal
cell type for the generation of iPSC biobanks. To address this issue we compared transcriptomic, epigenetic, and differentiation propen-
sities of geneticallymatched human iPSCs derived from fibroblasts and blood, two tissues of themost practical relevance for biobanking.
Our results show that iPSC lines derived from the same donor are highly similar to each other. However, genetic variation imparts a
donor-specific expression and methylation profile in reprogrammed cells that leads to variable functional capacities of iPSC lines. Our
results suggest that integration-free, bona fide iPSC lines from fibroblasts and blood can be combined in repositories to form biobanks.
Due to the impact of genetic variation on iPSC differentiation, biobanks should contain cells from large numbers of donors.INTRODUCTION
Although cell-fate decisions are fairly stable in vivo, so-
matic cells can be reprogrammed back into pluripotency
in vitro by ectopic expression of defined transcription fac-
tors (Takahashi and Yamanaka, 2006). Successful reprog-
ramming requires complete erasure of somatic cellmemory
and establishment of a pluripotent stem cell epigenetic
landscape (Nashun et al., 2015). Fibroblasts and peripheral
blood mononuclear cells (PBMCs) are commonly used for
reprogramming (Santostefano et al., 2015). Induced plurip-
otent stem cells (iPSCs) are known to be epigenetically
similar to human embryonic stem cells (hESCs) (Guenther
et al., 2010; Maherali et al., 2007), although several reports
have suggested retention of epigenetic memory related to
the cell of origin (Bar-Nur et al., 2011; Kim et al., 2010,
2011; Ohi et al., 2011; Polo et al., 2010). This phenomenon
can have functional consequences by influencing iPSC dif-
ferentiation propensity and biasing it toward the cell type
of origin at the expense of other lineages (Bar-Nur et al.,200 Stem Cell Reports j Vol. 6 j 200–212 j February 9, 2016 j ª2016 The Au2011; Kim et al., 2010; Polo et al., 2010). However, con-
flicting studies have shown that variations in directed dif-
ferentiation (Kajiwara et al., 2012) and transcriptional
heterogeneity (Rouhani et al., 2014) between iPSC lines
were ascribed to the genetic background of the donor.
iPSC biobanks can provide powerful material for
modeling human diseases and regenerative cell therapies.
However, the absence of systematic molecular and func-
tional studies of iPSC lines generated from different genetic
backgrounds and cell types of origin has hampered re-
programming efforts for large-scale biobanking pur-
poses. In particular, the omission of blood cells prevents
leveraging the resources of numerous biorepositories that
have collected blood cells for human genetic, metabolic,
and related studies. In this study we examined whether
comparable iPSC line collections can be established fromfi-
broblasts and blood. To address issues of donor genetic
background and cell type of origin, we produced geneti-
cally matched iPSC lines from fibroblasts and blood
from several donors and thoroughly investigated theirthors
Figure 1. iPSCs Derived from Fibroblasts and Blood Cells Are Transcriptionally Similar
(A) Schematic representation of the study. Genetically matched iPSC were produced from fibroblasts and blood cells (PBMCs) from four
female donors (T14, T42, T53, T55) using Sendai virus (SeVdp) mediated reprogramming. The cell lines used in this study are listed in
Table 1. Fibroblast-derived iPSCs (F-iPS) and blood-derived iPSCs (B-iPS) are shown in black and red, respectively, throughout the figures.
(B) PCA of global gene expression data of genetically matched F-iPSCs (n = 8) and B-iPSCs (n = 10) derived from four donors, two human
embryonic stem cell lines (hESC), and somatic cells of origin (n = 4/4). Characterization of iPSC lines is presented in Figure S1.
(C) Unsupervised hierarchical clustering of global DNA methylation profiles in genetically matched F-iPSC (n = 8) and B-iPSC (n = 10) lines,
somatic cells of origin (n = 4/4), and two hESC lines (H1, H9) performed on a single-nucleotide level using reduced representation bisulfite
sequencing.
(D) Pairwise correlation of the genetically matched F- and B-iPSC lines for each donor (T14, n = 4; T42, n = 5; T53, n = 5; T55, n = 4) after
local-pooled-error test. The entire list of genes for each donor is presented in Table S1. The direction of the correlation is visualized using
thin lines inside boxes, and the magnitude of correlation using the colors. Darker color corresponds to the higher correlation. Isogenic iPSC
lines derived from donor T42 display the lowest correlation.transcriptional and epigenetic status, as well as their spon-
taneous and multi-lineage hematopoietic differentiation
potential.RESULTS
Global Analysis of iPSC Lines Generated from
Genetically Matched Fibroblasts and Blood
Variation between iPSC lines has been attributed to many
factors, such as cell type of origin, donor, culture condi-
tions, and reprogramming method. To perform unambig-
uous studies on retention of cell-type memory, we gener-Stem Ceated isogenic iPSC lines from fibroblasts (F-iPSCs) and
PBMCs (B-iPSCs) by Sendai virus-mediated reprogram-
ming under standardized conditions (Figure 1A and Table
1) (Nishimura et al., 2011; Trokovic et al., 2014). To reduce
gender-associated variation, only female donors were
selected for the study. All iPSC lines expressed stem cell
markers and showed morphology and growth characteris-
tics similar to those of hESCs, and were propagated up to
passage 9–17 (Figures S1A and S1B; Table 1). All iPSC lines
were able to spontaneously differentiate into three embry-
onic germ layers in embryoid bodies (Figure S1C). To avoid
the confounding effects of partially reprogrammed cells,
only cell lines identified as bona fide iPSCs by PluriTestll Reports j Vol. 6 j 200–212 j February 9, 2016 j ª2016 The Authors 201
Table 1. Samples Used in the Study
Donor Sex Cell Line/Clone Number p Cell Type Donor Cell Type Array/No RRBS EB Array/No
T14 F T14F Fib yes/1 yes
T14BC PBMC yes/1 yes
T14F_iPS.1 10 iPSC Fib yes/2 yes yes/1
T14F_iPS.2 9 iPSC Fib yes/1 yes
T14BC_iPS.2 9 iPSC PBMC yes/1 yes yes/1
T14BC_iPS.3 9 iPSC PBMC yes/2 yes
T42 F T42F Fib yes/1 yes
T42BC PBMC yes/1 yes
T42F_iPS.1 15 iPSC Fib yes/1 yes yes/1
T42F_iPS.2 12 iPSC Fib yes/2 yes
T42BC_iPS.1 10 iPSC PBMC yes/2 yes
T42BC_iPS.2 14 iPSC PBMC yes/2 yes yes/1
T42BC_iPS.3 9 iPSC PBMC yes/2 yes
T53 F T53F Fib yes/2 yes
T53BC PBMC yes/2 yes
T53F_iPS.1 10 iPSC Fib yes/2 yes
T53F_iPS.2 9 iPSC Fib yes/1 yes yes/1
T53BC_iPS.1 11 iPSC PBMC yes/2 yes
T53BC_iPS.2 9 iPSC PBMC yes/1 yes yes/1
T53BC_iPS.3 9 iPSC PBMC yes/2
T55 F T55F Fib yes/2 yes
T55BC PBMC yes/2 yes
T55F_iPS.1 12 iPSC Fib yes/2 yes
T55F_iPS.2 17 iPSC Fib yes/1 yes yes/1
T55BC_iPS.1 17 iPSC PBMC yes/1 yes yes/1
T55BC_iPS.2 13 iPSC PBMC yes/2 yes
H9 F H9 46 hESC yes/2 yes yes/1
FES22 M FES22 56 hESC yes/1 yes/1
F, female; M, male; p, passage; Fib, fibroblast; RRBS, reduced representation bisulfite sequencing.(Muller et al., 2011) were selected for further experiments
(Figure S1D). To avoid batch effects in expression profiling
(Leek et al., 2010), we distributed F- and B-iPSC lines across
batches (Table 1). Global gene expression analysis of all
cell lines showed that pluripotent stem cells (PSCs) clus-
tered together and were clearly separated from their
parental cell lines (Figures 1B and S1E). Expression analysis202 Stem Cell Reports j Vol. 6 j 200–212 j February 9, 2016 j ª2016 The Auof genes located in X chromosome showed little variation
between lines (Figure S1F), suggesting that our female iPSC
lines retain an inactive X chromosome (Tchieu et al.,
2010). Global DNA methylation analysis performed at a
single-nucleotide level using reduced representation bisul-
fite sequencing (RRBS) (Meissner et al., 2005) also resulted
in a clustering of PSCs (Figure 1C). Interestingly, boththors
global DNA methylation and gene expression analyses
revealed a tendency of iPSC lines to cluster according
to the donor rather than cell type of origin (Figures 1C
and S1E).
Cell Type of Origin Contributes Minimally to iPSC
Variability
To analyze differences in expression profiles resulting
solely from the cell type of origin, we grouped iPSC lines
according to their parental cell type into two groups
(F- and B-iPSCs). The reproducibility-optimized test sta-
tistic (Elo et al., 2008) and significance analysis of micro-
arrays (SAM) (Tusher et al., 2001) identified only two
differentially expressed genes (TCERG1L and COL22A1)
between the iPSC groups. Using a separate statistical
test, two-group empirical Bayes method (BH, p < 0.05)
(Smyth, 2004), we identified only TCERG1L as a gene ex-
pressed significantly higher in B-iPSCs than in F-iPSCs.
To increase the power of analysis, we used an arbitrary
fold-change (FC) cutoff of >1. We subsequently identi-
fied 13 differentially expressed genes between F- and
B-iPSC groups. However, unsupervised hierarchical clus-
tering of all iPSC lines did not separate them into two
groups according to the cell type of origin (Figures S2A
and S2B). This suggests that the detected differences be-
tween iPSC lines were not due to different tissues of
origin.
To eliminate variability resulting from genetic back-
ground, we compared F- versus B-iPSCs for each donor.
Using a local-pooled-error (LPE) test, a statistical test well
suited for small sample sizes (Jain et al., 2003), we identified
24 (T14B- versus F-iPSCs), 13 (T42B- versus F-iPSCs),
6 (T53B- versus F-iPSCs), and 158 (T55B- versus F-iPSCs)
differentially expressed genes between the isogenic iPSC
lines (Figure 1D and Table S1). Of interest, we noticed
that T42- and T55-derived iPSCs showed larger intra-line
variability compared with T14- and T53-derived iPSC lines
(Figure S2C). MEG3 was the only common element for all
four donors. In addition, TCERG1L, COL3A1, and HAND1
were common between three donors (T14, T42, and T55)
(Figure S2D). These data are in line with previous studies
showing that the imprinted genes MEG3 and TCERG1L
are frequently differentially expressed between PSC lines
(Lister et al., 2011; Stadtfeld et al., 2010; Wang et al.,
2013). To increase the power of analysis we again used
the arbitrary FC cutoff >1 and identified 134–435 differen-
tially expressed genes between isogenic iPSC lines (Table
S2). After examination of gene ontology (GO) terms for
all groups, identified using LPE or FC >1 tests, we did
not find terms enriched for hematopoietic processes
that would suggest a cell type of origin bias. Together,
genome-wide transcriptomic analysis results show that
F- and B-iPSCs are highly similar to each other, suggestingStem Cethat cell type of origin is not a major factor resulting in
iPSC line variability.
Epigenetic Differences of iPSC Lines Are Minimally
Explained by Original Cell Type
In previous reports, different PSCs were shown to harbor
unique CpG methylation profiles due to either residual so-
matic cell memory or aberrant methylation (Lister et al.,
2011). To determine whether the epigenetic differences
result from the cell type of origin, we grouped iPSC lines
into F- and B-iPSCs and compared them using RRBS. In to-
tal we identified 655 differentially methylated CpG sites
(DMCs) (0.23% of common CGs). Hypermethylated
DMCs predominated in B-iPSCs (566 = 86.4% of DMCs)
compared with F-iPSCs (Figure 2A).
To eliminate donor-derived variability in methylation
profiles, we compared F- and B-iPSCs for each donor. We
identified the largest number of DMCs for isogenic iPSCs
derived from donor T42 (9,057 = 3.2%) followed by T55
(2,620 = 0.92%), T14 (2,142 = 0.76%), and T53 (795 =
0.28%) (Figure 2A). Of these, an average of 66% were
donor-unique DMCs, with the exception of T42-derived
F- and B-iPSC lines where 84% of the DMCs were unique
for that genetic background (Figure 2A). We identified 34
DMCs common to all four donors (Figure S2E). Notably,
eight of these common DMCs are in the TCERG1L locus
(Lister et al., 2011; Wang et al., 2013) (Figure 2B). The frac-
tion of CpGs differentially methylated between F- and
B-iPSCs is lower than between two different hESC lines
(H1 and H9) (Bock et al., 2011) (Figure 2A). This again sug-
gested that F- and B-iPSCs are highly similar to each other.
To quantify both abnormalmethylation and somaticmem-
ory phenotypes we compared the methylation signatures
of hESCs, isogenic iPSC lines, and somatic parental cells
using k-means clustering (Figure S3). We found that the
methylation profiles of 7%–25% of DMCs in iPSCs resem-
bled those of the corresponding parental somatic cells (Fig-
ure 2C), and often exhibited a donor-specific signature of
memory. On average, 70% of DMCs were similar to hESCs
(Figure 2C), which is in line with previous reports (Bock
et al., 2011).
Donor-Related Variability Influences Expression of
Lineage Priming Genes in iPSC Lines
As isogenic iPSC lines showed a tendency to cluster in pre-
vious analyses (Figures 1C and S1E), we next selected the
top 1,000 genes showing the largest variance in gene
expression between all PSC lines (Table S3). Unsupervised
hierarchical clustering using the 1,000 most variably ex-
pressed genes resulted in clustering of isogenic iPSC lines,
supporting our previous observation that differences
in gene expression were mostly donor dependent (Fig-
ure S4A). However, we also observed some variabilityll Reports j Vol. 6 j 200–212 j February 9, 2016 j ª2016 The Authors 203
Figure 2. Methylomic Analyses Demon-
strate Minimal Contribution of Source-Cell-
Specific Differences to iPSC Variability
(A) Total number of donor-unique, differen-
tially methylated cytosines (DMCs) between
genetically matched iPSC lines derived from
fibroblasts and blood cells. Analyses were
performed for each donor (T14, n = 4; T42, n =
5; T53, n = 5; T55, n = 4). The table shows the
number of DMCs per pairwise comparison as
well as the number of hypermethylated CpGs
and hypomethylated CpGs in B-iPSCs with
respect to F-iPSCs and H1 hESCs with respect to
H9. RRBS data for H1 hESCs were obtained from
the ENCODE project (Meissner et al., 2008).
(B) A heatmap representing methylation
level of the 34 common DMCs across all
pluripotent stem cells (n = 20) and somatic cell
lines (n = 8). DMCs were annotated at the
nearest transcription start site. ESC, embryonic
stem cells; PBMC, blood cells; F-iPS, iPSCs
derived from fibroblast; B-iPS, iPSCs derived
from blood.
(C) Aberrant methylation and somatic cell
memory in genetically matched F- and B-iPSC
lines (T14, n = 4; T42, n = 5; T53, n = 5; T55, n = 4) compared with embryonic stem cells (ESC). The bar chart represents the percentage of
the total number of DMCs. The list of values can be found in (A). Donors are indicated above the bars.between isogenic iPSC lines. GO analysis of these 1,000
genes indicated enrichment of categories representative
of developmental pathways (Table S4). The oPOSSUM algo-
rithm (Ho Sui et al., 2007) was used to identify regulatory
motif over-representation across the most differentially ex-
pressed genes. This indicated hits in transcription factors
related to the maintenance and differentiation of PSCs
(Table S5). To analyze this further, we focused on an inde-
pendent panel of genes associatedwith PSCs and their early
differentiation, selected by the International Stem Cell
Initiative (Adewumi et al., 2007). Unsupervised hierarchi-
cal clustering of iPSC lines according to the expression of
these genes resulted in clustering according to the donor,
confirming our previous findings that donor-dependent
characteristics influence expression of genes related to plu-
ripotency and differentiation (Figure S4B).
To further study the statistical differences between
isogenic iPSC lines, we grouped them based on the donor
(T14, T42, T53, and T55) and performed SAM on the
1,000 most variably expressed genes across all PSC lines.
This resulted in the identification of 167 differentially
expressed genes between the isogenic iPSC groups from
different donors (Table S6). Clustering of all samples
according to these genes was visualized as an annotated
heatmap (Figure 3A). Principal-component analysis (PCA)
using this167-gene set confirmed donor-specific clustering
(Figure S4C). Furthermore, when we annotated the DMCs204 Stem Cell Reports j Vol. 6 j 200–212 j February 9, 2016 j ª2016 The Auby assigning them to the nearest transcription start site
(TSS) (Table S7), we found that 29 of those 167 genes also
overlapped with donor-specific DMCs. These DMCs were
largely enriched in promoter regions (conventionally
defined as ±1 kb from TSS), supporting the hypothesis
that epigenetic differences reflect the transcriptional varia-
tion between iPSC lines derived from different donors
(Figure 3B). qPCR analyses on selected genes (MEG3,
WNT3A, SOX17, and SNAI2) replicated these results (Fig-
ure 3C). GO analysis of these 167 differentially expressed
genes primarily indicated biological processes related
to early development, which was confirmed using a
PANTHER over-representation test (Figures 3D and 3D0).
This suggests that donor-based variability has amajor influ-
ence on the expression of genes related to pluripotency and
lineage priming.
Spontaneous Differentiation Potential of F- and
B-iPSCs
We then used embryoid body (EB) analysis to investigate
the impact of somatic cell type- and donor-dependent
characteristics on the spontaneous differentiation poten-
tial of F- and B-iPSCs. Correlation clustering of global
gene expression showed no specific clustering of EBs
(Figure S5A). Although it has been reported that iPSC lines
preferentially differentiate into the lineage of the cell type
of origin, we were unable to detect any differentiation biasthors
Figure 3. Donor-Dependent Variability Affects Expression of Genes Related to Lineage Priming in iPSCs
(A) Annotated heatmap showing expression of 167 genes across all cell lines (n = 34). The entire list of 167 genes can be found in Table S6.
Individual cell lines used are indicated below the heatmap. The color bar on the right side demonstrates the log2 fold changes. B, blood
cells; F, fibroblasts; EBs, embryoid bodies.
(B) Donor-unique methylation signatures. The plot shows the distance of the donor-unique DMCs from the nearest transcription start site
(TTS) in a ±100-kb region. Genes (29) overlapping with donor-unique DMCs are listed. The density curve (black) shows the enrichment per
position.
(C) Verification of the genome-wide expression analysis with qPCR on selected genes (from A and B). Centerlines show the medians of
MEG3, WNT3A, SOX17, and SNAI2 genes relative to human embryonic stem cell line (H9). Box limits indicate the 25th and 75th percentiles
as determined by R software. Boxplots represent all iPSC lines for each donor (T14, n = 4; T42, n = 5; T53, n = 5; T55, n = 4; two technical
replicates). Heatmaps from genome-wide expression analysis for each gene are shown below the boxplot.
(legend continued on next page)
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toward any embryonic germ layer of specific lineage (data
not shown) or the hematopoietic lineages in particular
(Figure S5B) (gene list according to Bock et al., 2011).
Both F- and B-iPSC lines are able to differentiate into de-
rivatives of all three embryonic lineages despite the cell
type of origin. To examine whether EBs showed donor-
specific differentiation propensities, we analyzed the
expression of 167 genes that separated iPSC lines from
different donors (Table S6) and found that spontaneously
differentiated EBs maintained this difference (Figure 3A).
Together, these results indicate that the differences in
gene expression at the iPSC stage are maintained through
differentiation.
Hematopoietic Cell Lineage Differentiation of
Genetically Matched F- and B-iPSC Lines
To determine the functional consequences of donor-
related transcriptional and epigenetic differences, we
differentiated iPSC lines toward the hematopoietic lineage
using a previously described protocol (Ronn et al., 2015;
Woods et al., 2011). We selected iPSC lines derived from
two donors (T42 and T55) showing the largest transcrip-
tional and epigenetic intra-line variability (Figure 1D). We
used fluorescence-activated cell sorting (FACS) to identify
frequencies of hematopoietic cells (CD45+), progenitors
(CD45+ CD34+), and more developmentally immature
hematopoietic cells (CD43+) (Figure 4A). There was no dif-
ference between isogenic F- and B-iPSC lines (Figure 4B).
Hematopoietic and hematopoietic progenitor cells showed
similar frequencieswhenwe compared iPSC differentiation
potential between two donors (Figure 4). However, donor
T42 yielded significantly fewer mature hematopoietic cells
than T55 (Figure 4C). Interestingly, microscopic analysis
revealed fewer large hemoglobinized erythroid cell clusters
in iPSC lines derived from donor T42 than from T55
(Figure 5A). FACS analysis using erythroblast markers
(CD45 CD33  glycophorin A [GPA]+, transferrin
[CD71]+) confirmed the reduced erythroid potential of
T42 iPSC lines compared with T55 (Figures 5B and 5C).
To evaluate the functionality of these cells, we plated
them into methylcellulose and measured their erythroid
colony-forming potential. iPSC lines derived from donor
T42 yielded fewer erythroid colonies than those from T55
(Figure 5D). These results demonstrate that iPSC lines
derived from different donors can possess significant vari-
ability in lineage commitment potential irrespective of
their cell source.(D) Boxplots showing the mean values of gene expression (log2) of 167
cell lines (FES22, H9), and iPSC lines derived from four different don
(D0) Gene ontology analysis for the 167 genes analyzed using the PA
testing was applied. Only results with p < 0.05 are displayed.
206 Stem Cell Reports j Vol. 6 j 200–212 j February 9, 2016 j ª2016 The AuCharacterization of Molecular Mechanisms
Underlying Variable Erythroid Differentiation
Potential
Next, we applied gene set enrichment analysis (GSEA) to
examine the expression of functionally related genes.
iPSC clones from donor T42 (F-iPS2 and B-iPS1) showed
downregulation of genes (25 of 61 genes; false discovery
rate [FDR] = 0.002, normalized enrichment score [NES] =
2.2084) associated with Diamond-Blackfan anemia
(DBA), which is functionally characterized by diminished
erythroid precursor cells (Figure 5E) (Gazda et al., 2006).
The finding was reproducible with two additional clones
from the same donor (17 of 61 genes; FDR = 0.001, NES =
2.2400) (Figures S6A and S6B). Altogether, 15 overlapping
genes were identified between these two sets (Figure S6C).
We also asked whether differentiation potential and the
noted differential gene expression differences between
the lines can be linked to changes in methylation. We con-
ducted additional comparisons between (T42F-iPS2, T42B-
iPS1) and (T55F-iPS2, T55B-iPS1) for DMCs of 25%ormore,
and annotated to the TSS of the nearest protein coding
gene. We found several genes that are likely involved in
the differentiation of the lines to contain DMCs (Table
S8). For example, we found that CpGs associated with
NUCB2 and RB1 were more highly methylated in cells
derived from donor T55 than T42. Reciprocally, CpGs asso-
ciated with the genes CPSF6, IBTK, and PFDN4 were more
highly methylated in T42 than in T55.
Interestingly, the same hematopoietic tendency was
observed independently in EBs derived from donor T42
and T55. Global gene expression patterns showed 7- to
16-fold upregulation of embryonic and fetal hemoglobin
gene expression (HBE1, HBA2, HBG1, and HBG2) in EBs
derived fromT42 in comparisonwithT55. Elevated fetal he-
moglobin production has been associated with a reduced
total number of circulating erythrocytes in DBA patients
(Alter, 1979) and a group of disorders called hereditary
persistence of fetal hemoglobin (Forget, 1998). Moreover,
of the 66 genes present in the DBA gene set noted above,
a total of eight of theseweremaintained as differentially ex-
pressed in the EB stage in donor T55 compared with T42:
CASP6, CNOT8, IFT74, LSM5, LYPLA1, PFDN4, PRSS2, and
SPAST. In addition, we observed 1- to 12-fold upregulation
of megakaryocyte-specific genes (FLI1, MPL, GP9/CD42a,
CD36, ITGA2B/CD41) and a 2- to 30-fold upregulation of
myeloid lineage genes (MPO, CSF1R, SPI1, CSF3R) in EBs
derived from T42 compared with T55 (Figures S6D–S6F).genes (shown in A and listed in Table S6) in human embryonic stem
ors (T14, n = 4; T42, n = 5; T53, n = 5; T55, n = 4).
NTHER over-representation test. Bonferroni correction for multiple
thors
Figure 4. Genetically Matched F- and B-iPSCs Have Similar
Hematopoietic Differentiation Capacity
(A) Representative FACS profiles of differentiated genetically
matched F- and B-iPSC lines (F in black, B in red) from two donors.
Green (T42) and blue (T55) colors mark iPSC lines derived from
different donors. The plots show the percentage of hematopoietic
cells (CD45+) and hematopoietic progenitors (CD45+ CD34+),
immature (CD45+ CD43+), and more mature hematopoietic cells
(CD45+ CD43).
(B) Assessment of variability resulting from cell type of origin.
Percentages of hematopoietic cells, hematopoietic progenitors,
and mature hematopoietic cells are shown in scatterplots.
(C) Assessment of variability resulting from donor genetic back-
ground. Bar graphs show average percentage of hematopoietic
cells, hematopoietic progenitors, and mature hematopoietic cells,
Stem CeDISCUSSION
Four major observations emerge from this study. First, we
show that source-cell-specific differences are not retained
to a significant extent in isogenic iPSC lines. This is in
line with a recent report (Rouhani et al., 2014), but con-
trasts with earlier studies which observed disruptive reten-
tion of somatic cell memory in iPSC lines (Bar-Nur et al.,
2011; Kim et al., 2010; Polo et al., 2010). Long-term culture
has shown to be advantageous in erasing cell-type-specific
memory (Kim et al., 2010; Polo et al., 2010), diminishing
transcriptional differences between human iPSC and ESC
lines (Chin et al., 2010), and eliminating genetic mosai-
cism (Hussein et al., 2011). In addition, we used the all-
in-one type footprint free SeVdp-iPS system for generation
of uniform iPSC lines (Nishimura et al., 2011). We per-
formed molecular analyses at later passages and obtained
highly similar molecular signatures for genetically
matched iPSC lines derived from two different tissues,
even though fibroblasts and PBMCs include multiple cell
populations with distinct epigenetic and transcriptional
landscapes (Sorrell and Caplan, 2004; Zhang and Huang,
2012).
Our data show that the majority of transcriptional and
epigenetic signatures present in iPSCs are donor deter-
mined. This is well in line with recent studies that have
suggested the influence of genetic background on tran-
scription (Rouhani et al., 2014; Shao et al., 2013) and differ-
entiation of iPSC lines (Kajiwara et al., 2012; Mills et al.,
2013). Also, embryonic stem cells derived from individual
donors are shown to maintain line-specific signatures and
have distinct differentiation potentials (Bock et al., 2011;
Chen et al., 2009; Osafune et al., 2008). Our present data
point out that donor-dependent signatures specifically
affect gene expressions involved in early embryonic line-
age specification, resulting in variability between iPSC
lines.
Third, we show that iPSC differentiation propensities are
significantly biased by donor-dependent variability and
not by cell type of origin. Earlier studies have focused on
the relationship between genetic variability and molecular
signatures of iPSC lines (Kajiwara et al., 2012; Rouhani
et al., 2014; Shao et al., 2013). However, only limited infor-
mation was available on the contribution of donor back-
ground to the functional differences of iPSC lines arising
from the source-cell-specific differences. This was thor-
oughly addressed in the present study by combining globaldifferentiated from isogenic F- and B-iPSC lines. Donors are indi-
cated in green (T42) and blue (T55). Values are mean ± SEM. Sta-
tistics performed by Student’s t test, in three or four biological
replicates.
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Figure 5. iPSCs Derived from Different Donors Show Variable Erythroid Lineage Differentiation Propensity
(A) Representative micrographs showing the hematopoietic cells differentiated from iPSCs with reduced hemoglobinized erythroid cells in
iPSCs derived from T42 (left panel). Scale bar, 100 mm.
(B) Representative FACS plots of differentiated genetically matched F- and B-iPSC lines (n = 4) showing the percentage of erythroblasts
(GPA+ CD71+ gated from CD45 CD33).
(C) Scatter graphs presenting percentage of erythroblasts generated from the genetically matched F- and B-iPSC lines. Each dot represents
an independent experiment.
(D) Percentage of erythroid colonies out of the total colony number generated from iPSC lines. Values are mean ± SEM. Statistics performed
by Student’s t test, in three or four biological replicates.
(E) Gene set enrichment plot and heatmap showing the genes constituting the core enrichment of overlap between multi-potent pro-
genitors sorted from the bone marrow of DBA patients and iPSC lines derived from T42 cells. T42 iPSC lines show decreased expression levels
of genes that are downregulated in Diamond-Blackfan anemia patients.transcriptional and epigenetic analyses with spontaneous
and targeted differentiation of isogenic iPSC lines.
Although we selected iPSC lines from healthy donors
showing the highest intra-individual variation in transcrip-
tional and epigenetic analyses, we could not detect major
differences in the differentiation potential of isogenic
iPSC lines originating fromfibroblasts and blood. However,208 Stem Cell Reports j Vol. 6 j 200–212 j February 9, 2016 j ª2016 The Auwe detected donor-dependent transcriptional differences
in spontaneously differentiated EBs and significant varia-
tion in erythroid differentiation potential between iPSC
lines derived from two healthy donors, regardless of the
cell type of origin. Using GSEA we were able to associate
the low erythroid-forming potential of the healthy donor
to genes previously indicated in DBA. Moreover, thethors
Figure 6. Implications for Biobanking
iPSCs generated from genetically different donors show transcrip-
tional and epigenetic variation, which is reflected in variable dif-
ferentiation propensities. iPSC lines generated from genetically
matched fibroblasts and blood cells are molecularly and function-
ally similar, implying that iPSCs derived from different tissues can
be combined in repositories.differential expression of these genes in different donors at
the iPSC stage was, at least in part, maintained through dif-
ferentiation to EBs, providing further evidence in support
of the donor-related differences affecting the differentia-
tion potential of iPSC lines.
Finally, an important practical implication of our data is
that both fibroblasts and blood can be used for the genera-
tion of comparable iPSC lines for large-scale biobanking
purposes (Figure 6). Our results demonstrate that vari-
ability among small cohorts of iPSCsmay lead to erroneous
conclusions (Sandoe and Eggan, 2013). Because of the
inherent differences resulting from the donor-dependent
variability, it seems obvious that relatively large cohorts
of iPSC lines from different donors, rather than several
isogenic clones from a few donors, would be needed to
obtain reliable results concerning the impact of donor-spe-
cific variants. However, the fact that intra-individual clonal
variation is still present after careful technical standardiza-
tion and iPSC characterization also suggests that geneti-
cally matched clones from the donor should be available
in biobanks.Stem CeEXPERIMENTAL PROCEDURES
Ethical Statement
Skin biopsies and blood samples were collected from Takotsubo
cardiomyopathy patients with written consent permitted by the
Ethical Committee for Internal Diseases of the Hospital District
of Helsinki and Uusimaa (permit no: 352/13/03/01/2009). In brief,
Takotsubo cardiomyopathy mimics acute myocardial infarction
with similar symptoms and findings, but without coronary artery
disease. Patients develop transient congestive heart failure under
emotional or physical stress, but recover fully. Takotsubo occurs
almost exclusively among post-menopausal women. All donors
were females without any hematological medical condition.
Reprogramming, Cell Culture, and Fingerprinting
Fibroblasts were grown from skin biopsies under glass plates in
DMEM + 20% fetal calf serum and antibiotics. Mononuclear cells
were extracted freshly from blood by Ficoll-extraction method.
PBMCs (1 3 105 to 1 3 106) and fibroblasts were transduced
with SeVdp as previously described (Nishimura et al., 2011;
Trokovic et al., 2014). Cells were plated on mitomycin C-treated
murine embryonic fibroblasts (3.75 3 105 feeder cells/well) on a
six-well plate in hES medium: DMEM/F12 with GlutaMAX, sup-
plemented with 20% KO-serum replacement, 0.1 mM b-mercap-
toethanol, 1% non-essential amino acids (all from Life Technol-
ogies), and 6 ng/ml basic fibroblast growth factor (bFGF; Sigma).
For feeder-free cultures iPSC lines were grown on Matrigel
(growth factor reduced, BD Biosciences) in StemPro (Life Tech-
nologies) or in Essential-8 medium (E8, Life Technologies). The
donor identity of all iPSC lines was confirmed by microsatellite
marker analyses.
Characterization of iPSC Lines
iPSC lineswere characterized for expression of stem cellmarkers by
RT-PCR and immunofluorescence microscopy as previously
described (Trokovic et al., 2013, 2014). For immunofluorescence
analyses we used stem cell-specific antibodies against TRA-1-60
(Millipore, MAB4360), NANOG (Cell Signaling, D73G4), SSEA4
(Millipore, MAB4304), and OCT4 (Santa Cruz Biotechnology,
sc-9081). Cell nuclei were stained with DAPI (Vectashield, Vector).
The raw expression data of all iPSC clones was analyzed by
PluriTest (http://www.pluritest.org/) and only the clones that suc-
cessfully passed the test were selected for further analyses (Muller
et al., 2011).
EBs were grown from each iPSC clone in low-attachment plates
(Corning) in hES medium without bFGF. After 21 days, total
RNA was extracted for expression analyses using an AllPrep
DNA/RNA/Protein kit (Qiagen). Germ layer-specific expression of
EBs was analyzed using antibodies which recognize b-III-tubulin
(R&D Systems, MAB1195), AFP (DAKO, A0008), and vimentin
(Dako, M0725).
Gene Expression Profiling
Total genomic DNA/RNAwas extracted from all cells using AllPrep
DNA/RNA/Protein kit (Qiagen) according to the manufacturer’s
instructions. Gene expression analysis was performed at the Insti-
tute for Molecular Medicine Finland (FIMM) Technology Center,ll Reports j Vol. 6 j 200–212 j February 9, 2016 j ª2016 The Authors 209
University of Helsinki, using Illumina Human-12 v4 Expression
BeadChips. For further analyses, data were processed by removal
of background and quantile normalization. The data analysis was
performed with R statistics and Chipster (Kallio et al., 2011). All
iPSC lines analyzed were between passages (p) 9 and 17. Genes
were filtered on the basis of their SD (2 SDs = 95%).
Comparative analysis between F- and B-iPSCs was performed us-
ing LPE test. p-Value cutoff was <0.05 and the FDR was controlled
by adjusting the p value with Benjamini-Hochberg. An interactive
tool for comparing lists with Venn diagrams was done at http://
bioinfogp.cnb.csic.es/tools/venny/index.html. Gene lists were
analyzedwithDAVID (Huang da et al., 2009). For pathway analysis
we used the PANTHER Classification System (Thomas et al., 2003).
Microarray data are available in the ArrayExpress database (www.
ebi.ac.uk/arrayexpress) under accession number E-MTAB-3825.
Microarray data were confirmed using qPCR. cDNAs for qPCR re-
actions were produced from the extracted RNA samples (2 mg) by
Maxima First Strand cDNA synthesis kit (Thermo Scientific).
qPCR was performed with EvaGreen qPCR mix (Solis Biodyne) in
Corbett RotorGene. Primers used NANOG F/R (CTC AGC CTC
CAG CAG ATG C/TA GAT TTC ATT CTC TGG TTC TGG); SOX17
F/R (CCG AGT TGA GCA AGA TGC TG/T GCA TGT GCT GCA
CGC GCA); SNAI2 F/R (GGT TGC TTC AAG GAC ACA TTA G/TT
GAC CTG TCT GCA AAT GCT C); MEG3 F/R (AAG GAC CAC
CTC CTC TCC AT/A GGA AAC CGT GCT CCT AGT G); and
WNT3A (GCC CCA CTC GGA TAC TTC T/GG CAT GAT CTC
CAC GTA GT).
DNA Methylation Analysis
RRBS was performed on 500 ng of genomic DNA for all cell lines as
previously described (Gu et al., 2010). All libraries have been
sequenced to an average of 1,500,000 individual CpG per sample
at a genomic coverage of 53 or higher. Raw reads were mapped us-
ing Bismark (Krueger and Andrews, 2011), andmethylation calling
was performed using a custommethod. Methylation analysis, un-
supervised hierarchical clustering, PCA, and pairwise comparisons
were performed using MethylKit. Differential methylation was
calculated using Fisher’s exact test. A cutoff of 25% was applied
based on a difference in methylation level. p Values were adjusted
using SLIM method and a cutoff of FDR % 0.01 was applied.
Genomic annotation was performed using Homer annotation
(Heinz et al., 2010). Data analysis was performed with the R statis-
tics package (http://www.r-project.org/). RRBS data are available
in the ArrayExpress database (www.ebi.ac.uk/arrayexpress) under
accession number E-MTAB-3859.
Differentiation of Human iPSCs into Hematopoietic
Cells
Hematopoietic cell differentiation was performed as previously
described (Ronn et al., 2015; Woods et al., 2011). Micrographs of
cells from the cultures were taken at day 22 prior to whole well
harvest. Floating and individualized cells were pooled, washed,
and divided into two samples. One samplewas used for assessment
of hematopoietic lineage markers using FACS. The other sample
was plated into methylcellulose (MethoCult H4435, StemCell
Technologies) for colony-forming unit assay. The cells for FACS
analysis were stained for mouse anti-human CD45/CD43/CD34/210 Stem Cell Reports j Vol. 6 j 200–212 j February 9, 2016 j ª2016 The AuCD71 antibodies (BD Pharmingen; CD71APC, cat. no. 551374,
clone M-A712. CD45 FITC or PE cat. no. 555482, 555483, clone
HI30. CD43FITC cat. no. 555475, clone 1G10. CD34APC cat. no.
555824, clone 581), CD33/CD235a (GPA) antibodies (eBioscience,
CD235a(Gly-A) cat. no. 12-9987-82, clone HIR2(GA-R2). CD33PE-
Cy7 cat. no. 25-0338-42 cloneWM-53(WM53)) and analyzed by a
FACSCanto II flow cytometer.
Microarray data were evaluated at the level of gene sets to define
and quantitate trends in gene expression similar to published
data. Ranked gene lists were created and submitted to the online
public repository provided by the BROAD Institute for Gene Set
Enrichment Analysis (GSEATo) (Subramanian et al., 2005). Venn
diagram analysis was performed using Microsoft PowerPoint tool
software.
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